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BACKGROUND: The difficulties adolescents and young adults (AYAs) encounter during a cancer experience may result in a reduction
in or absence of empowerment. The aims of the current study were to assess levels of empowerment and associated (demographic,
clinical, or psychological) factors and examine the association between empowerment and health-related quality of life (HRQOL)
among AYA patients with cancer. METHODS: Patients aged 18 to 35 years at time of cancer diagnosis and who were seen by 1 of the
members of the specialized multidisciplinary AYA team of the Radboud University Medical Center were invited to complete question-
naires regarding empowerment; HRQOL; and sociodemographic, clinical, and psychological characteristics (autonomy, coping, unmet
social support needs, and psychological distress). RESULTS: A total of 83 AYA patients completed the questionnaires. The mean age
of the participants at the time of diagnosis was 27.5 years. The vast majority had been treated with chemotherapy (86%), had a more
advanced stage of disease, and had completed treatment at the time of participation (74%). The mean empowerment level was 154.1
(standard deviation, 17.8) with a range of 114 to 200. Multivariate analysis demonstrated that the autonomy subscales of self-
awareness (b 5 .35), capacity for managing new situations (b 5 .19), and social support (b 5 .35) were found to be positively associ-
ated with empowerment. Coping difficulties (b 5 -.19) were found to be negatively associated with empowerment. Empowerment
was independently associated with physical (b 5 .31), psychological (b 5 .50), social (b 5 .39), religious (b 5 .33), and total HRQOL
(b 5 .52; all P<.01). CONCLUSIONS: Low levels of empowerment were associated with low levels of autonomy and social support,
female sex, and coping difficulties among AYA patients with cancer. Recognizing these patients as candidates for empowerment
interventions ultimately could help to improve HRQOL in late adolescence and young adulthood. Cancer 2017;123:4039-47. VC 2017
The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under
the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
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INTRODUCTION
Adolescents and young adults (AYAs) diagnosed with cancer between the ages of 18 to 35 years form a distinct group between
pediatric and adult oncology.1 Our definition of AYA (those aged 18-35 years) is based on the organization of the health care
system in the Netherlands, in which there is a clear distinction between pediatric (ages birth-18 years) versus medical oncol-
ogy. According to Barr et al, “there is broad agreement but less than unanimity that adolescence ranges from 15 to 19 years
of age, resulting in young adulthood beginning at age 20 years.” Therefore, the age range of 18 to 35 years used herein
appears to indicate late adolescence and young adulthood.2 In the Netherlands, approximately 2700 AYA patients are diag-
nosed with cancer annually, which is approximately 5 times the number of cases diagnosed in children aged birth to 17 years.3
In addition to differences in tumor biology, limited progress in survival, lower clinical trial participation rates, and insufficient
awareness of cancer symptoms among patients and professionals, this group has distinctive psychosocial and supportive care
needs compared with their younger and older counterparts.1 Late adolescence and young adulthood is a period of complex
development; for example, it is during this period that one creates one’s own identity and body image, and establishes auton-
omy, responsibility, and independence. A cancer diagnosis poses existential questions to AYA patients regarding their future,
encompassing premature confrontation with mortality; changes in physical appearance; increased dependence on parents;
potential loss of reproductive capacity; and disruptions in social life, education, and employment due to treatment. These fac-
tors may have a negative impact on health-related quality of life (HRQOL).4
Empowerment is a factor that may be associated with HRQOL and has become a topical issue in cancer survivorship
over recent years.5-10 With its roots in community psychology, empowerment originally was defined as “the mechanism
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by which people, organizations, and communities gain
mastery over their lives.”11 The topical nature and the
extensive (mis)use of empowerment in health care has led
to a lack of clarity in regard to its definition and measure-
ment.12 For example, empowerment can be viewed as a
process versus an outcome, and on an individual versus
collective level.12-14 For the current study, we used the
construct of psychological empowerment of Zimmer-
man15 that views empowerment as an outcome measure
on the level of the individual patient: “psychological
empowerment is a feeling of control, a critical awareness
of one’s environment and active engagement in it.”15 In
accordance with a recent review on measuring and defin-
ing empowerment in patients with cancer,16 Zimmerman
states that empowerment reflects a broad construct and
comprehends intrapersonal, interactional, and behavioral
components.15 The intrapersonal component refers to
how people think about themselves and includes per-
ceived control, self-efficacy, and perceived competence
and mastery. The interactional component refers to how
people think about and relate to their social environment,
and the behavioral component of empowerment relates to
concrete behaviors of a person to change his or her situa-
tion (eg, active coping and participation in decision
making).14,15
Empowered AYA patients with cancer may be more
likely to understand and participate in their own care by
mobilizing resources and taking actions that can reduce
distress, enhance strategies for dealing with cancer, and
improve HRQOL.5,6 In view of this knowledge, it is
important to evaluate which sociodemographic (eg, sex),
clinical (eg, treatment intent), and psychological (eg, loss
of autonomy, coping difficulties, high levels of psycholog-
ical distress, and unmet social support needs) factors are
associated with low levels of empowerment among AYA
patients with cancer. This also may help us to identify
those patients who might benefit from additional support
or interventions.
The objectives of the current study were to assess the:
1) levels and associated factors (demographic, clinical, and
psychological) of empowerment; and 2) the association
between empowerment and HRQOL among AYA
patients.
MATERIALS AND METHODS
Participants
Patients aged 18 to 35 years at the time of cancer diagnosis
and who had been seen by at least 1 of the members of the
AYA team of the Radboud University Medical Center in
The Netherlands were invited to participate in the current
study. The AYA team is a dedicated multidisciplinary
team including a medical oncologist, clinical nurse spe-
cialist, medical psychologist, and social worker. Patients
consulting the AYA team receive regular medical care
from their own treating medical specialist in the Radboud
University Medical Center (medical oncologist, hematol-
ogist, surgeon, gynecologist, etc) and visit the AYA team
for age-specific questions and care needs. In general,
patients visiting the AYA team represent a group of pa-
tients with high disease severity, who are diagnosed with a
relatively advanced stage of disease and are undergoing
intensive treatments, and who are reporting more difficul-
ties with coping. Patients with lower stage disease (eg, cer-
vical cancer or melanoma) who are treated solely by
surgery are not often seen by the AYA team.
For the current study, AYA patients with cancer
were included independently of the status of treatment
(during or after treatment), the type of treatment (surgery,
chemotherapy, radiotherapy, immunotherapy/targeted
therapy and hormonal therapy, or a combination), or the
number of AYA team visits (some patients only had 1
introduction talk with one of the members of the team
and did not receive specific care thereafter) to depict the
real-life heterogeneous sample of AYA patients with can-
cer who are visiting the AYA team. Inclusion commenced
January 2012 and endedMarch 2016.
Procedure
Potential study participants were recruited via letters
describing the study and inviting patients to participate.
Patients who were willing to participate had to actively
opt-in to the study by providing written informed consent
by E-mail to a member of the AYA team. Participants
were then sent a single set of questionnaires by E-mail that
could be completed online. The study was deemed
exempt from full review and approval by a research ethics
committee (CMORegio Arnhem-Nijmegen).
Measures
Empowerment
The Cancer Empowerment Questionnaire (CEQ) is
based on Zimmerman’s theory of psychological empower-
ment and to the best of our knowledge is one of first
empowerment questionnaires validated in patients with
cancer.8,15,16 Validation in survivors of breast cancer pro-
vided a 4-factor structure representing the intrapersonal
and interpersonal strengths of patients with cancer.8 The
CEQ consists of 40 items with 4 subscales: Personal
Strength (19 items [range, 19-95]; a 5 .90), Social
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Support (9 items [range, 9-45]; a5 .76), Community (6
items [range, 6-30]; a 5 .81), and Health Care (6 items
[range, 6-30]; a 5 .78). Personal Strength encompasses
intrapersonal aspects of empowerment regarding self-
efficacy, self-esteem, optimism, and personal competence.
The remaining 3 subscales represent the interpersonal
aspects of empowerment with items of perceived support
from individuals close to the patient (Social Support),
feelings of acceptance and support from the social com-
munity (Community), and the perception of good and
collaborative relationships with health care professionals
(Health Care). Examples of questions regarding each sub-
scale are: “I think I am worthwhile” (Personal Strength),
“The people around me accept me” (Social Support),
“The society respects my rights as a citizen” (Commu-
nity), and “My health care professionals are there when I
need them” (Health Care). The 40 items are rated on a 5-
point Likert scale ranging from 1 (strongly disagree) to 5
(strongly agree). Total scores (scale) can range from 40 to
200. Stronger feelings of empowerment are indicated by
higher scores.8 Baseline internal consistency was good
(Cronbach a, .93).
Health-related quality of life
The Quality of Life-Cancer Survivors (QoL-CS) ques-
tionnaire measures the HRQOL of patients with cancer.
It consists of 41 items on the physical, psychological,
social, and religious impact of cancer on the life of the
patient. Respondents rate themselves along an interval rat-
ing scale ranging from 0 to 10 for each item. For subscale
scoring purposes, all items were ordered so that 0 indi-
cated the lowest or worst possible HRQOL and 10 indi-
cated the highest or best possible HRQOL outcome. An
overall QOL score was computed by averaging all 41
items.17
Associated Factors
Sociodemographic and clinical characteristics
Demographic data, including age, sex, partnership, hav-
ing children, living situation, educational level, and emp-
loyment status were gathered by self-report. Medical data,
including tumor type, disease stage, type(s) of treat-
ment(s) received, treatment status (on/off treatment), and
time since the initial diagnosis were extracted from the
patients’ medical records by 2 of the researchers (S.E.J.K.
and S.v.D.).
Autonomy-connectedness
The Autonomy-Connectedness Scale (ACS-30) question-
naire measures individual differences in autonomy-
connectedness (ie, the capacity for self-governance, inclu-
ding in social relationships). It consists of 30 items
divided into 3 subscales: Self-Awareness (7 items [eg, “I
often do not know what my opinion is”]), Sensitivity to
Others (17 items [eg, “I often wonder what other people
think of me”]), and Capacity for Managing New Situa-
tions (6 items [eg, “I quickly feel at ease in new sit-
uations”]). All items are measured with 5-point scales
ranging from disagree to agree.18,19 Internal consistency
in this study was good, with a values of .81, .82, and .80,
respectively.
Psychological distress
Psychological distress was assessed with the Hospital Anx-
iety and Depression Scale (HADS), with 7 items each for
assessing symptoms of anxiety and depression. All items
were scored on a 0-point to 3-point scale, with higher
scores indicating more symptoms. A total score was calcu-
lated, with higher scores indicating more distress.20
Social support and coping
Two items (amount of social support and coping difficul-
ties) were added as separate correlates for empowerment.
They were selected from the QoL-CS questionnaire.17
The question regarding the amount of social support was:
“Was the amount of support you received from others
sufficient?” For coping difficulties, the question was:
“How difficult is it for you nowadays to cope with the
effects of disease and treatment?” Respondents rate them-
selves along an interval rating scale ranging from 0 to 10
for each item. For social support, a higher score indicates
sufficient social support, whereas a higher score on the
coping subscale indicates more coping difficulties.
Statistical Analysis
Analyses were performed using SPSS statistical software
(version 22; IBMCorporation, Armonk, NY) and 2-sided
P values <.05 were considered statistically significant.
Descriptive statistics and frequencies concerning sociode-
mographic and clinical data, levels of empowerment, and
correlates were calculated. Pearson and Phi correlations
were calculated to examine associations between 2 contin-
uous variables and continuous and dichotomous variables,
respectively. This first was performed for correlates of lev-
els of empowerment and thereafter was performed for cor-
relates of HRQOL. To determine independent effects of
covariates on levels of empowerment and HRQOL,
respectively, multivariate linear regression analyses were
performed including only those covariates that were sig-
nificant at the bivariate level.
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RESULTS
Sociodemographic and Clinical Patient
Characteristics
In total, 309 letters requesting participation in the study
were sent to AYA patients with cancer who were visiting 1
of the members of the AYA team. A total of 89 patients,
comprising 57% of those who opted to take part in the
study (155 patients) and 29% of those invited (309
patients) completed the online questionnaire. Six patients
were excluded due to age criteria: 4 were diagnosed with
cancer at age <18 years and 2 were aged >35 years at the
time of diagnosis. Table 1 shows sociodemographic, dis-
ease, and treatment-related characteristics of the final sam-
ple (83 patients). The mean age at the time of diagnosis
was 27.5 years (standard deviation [SD], 4.6 years) with a
range of 18 to 35 years and a median age at diagnosis of
27 years. Three patients (3.6%) were aged 18 and 19
years. The average time since diagnosis was 2.1 years (SD,
2.6 years) and 86% of patients received curative treat-
ment. Of the participants, 52% were male. The most
commonly diagnosed cancers were testicular cancer
(34%) and sarcoma (19%).
Levels of Empowerment
The mean empowerment level was 154.1 (SD, 17.8), with
a range of 114 to 200. The mean scores for each domain
were 74 (SD, 9.8) for Personal Strength, 36.5 (SD, 4.1)
for Social Support, 19.7 (SD, 4.6) for Community, and
23.9 (SD, 3.4) for Health Care.
Associated Factors of Empowerment
Factors associated with total empowerment and the 4
empowerment subscales are presented in Table 2. Female
TABLE 1. Characteristics of the AYA Patient Study
Sample
Characteristic
Total 5 83
(%)
Sex
Male 43 (52%)
Female 40 (48%)
Mean age at diagnosis (SD), y 27.5 (4.6)
Mean age at survey (SD), y 29.6 (4.8)
Mean time since cancer diagnosis (SD), y 2.1 (2.6)
Cancer diagnosis
Testicular cancer 28 (34%)
Sarcoma 16 (19%)
Breast cancer 10 (12%)
Lymphoma/leukemia 10 (12%)
Gynecological cancer 9 (11%)
Melanoma 3 (4%)
Othera 7 (8%)
AJCC TNM staging system stage of disease
NA 9 (11%)
I 11 (13%)
II 25 (30%)
III 13 (16%)
IV 18 (22%)
Unknown 7 (8%)
Treatment intention
Curative 71 (86%)
Palliative 12 (14%)
Treatment status
Active 22 (26%)
Completed 61 (74%)
Treatment type (yes)
Surgery 70 (84%)
Chemotherapy 72 (87%)
Radiotherapy 24 (29%)
Immunotherapy/targeted therapy 13 (16%)
Hormonal therapy 7 (8%)
Systemic therapy other 13 (16%)
Partner
Yes 58 (70%)
No 24 (29%)
TABLE 1. Continued
Characteristic
Total 5 83
(%)
Children
Yes 27 (33%)
No 55 (66%)
Living situation
With parents 14 (17%)
On own 24 (29%)
With partner 44 (53%)
Highest completed educationb
Low/intermediate 38 (46%)
High 44 (53%)
Employed/studying
Yes 68 (82%)
No 15 (18%)
Received social support meeting needs, mean (SD)c 8.1 (1.8)
Coping with effects of cancer and its treatment, mean (SD)d 4.1 (2.6)
Psychological distress, mean (SD)e 11.0 (6.6)
Autonomy connectedness, mean (SD)
Self-awarenessf 25.9 (6.1)
Sensitivity to othersg 57.2 (10)
Handle new situationsh 19.2 (5.5)
Abbreviations: AYA, adolescent and young adult; NA, not applicable; SD,
standard deviation.
Not all numbers add up to 83 because of missing data.
a Brain tumor in 1 patient, sigmoid carcinoma in 1 patient, oropharyngeal can-
cer in 1 patient, neuroendocrine tumor in 1 patient, salivary gland cancer in 1
patient, adrenal carcinoma in 1 patient, and lung cancer in 1 patient.
b 0 indicates low/intermediate vocational education or less and 1 indicates
high-level vocational education/university.
c Score ranges from 0 to 10, with a higher score indicating more social
support.
d Score ranges from 0 to 10, with a higher score indicating more coping
difficulties.
e Score ranges from 0 to 42, with a higher score indicating more distress.
f Score ranges from 7 to 35, with a higher score indicating more self-
awareness.
g Score ranges from 17 to 85, with a higher score indicating more sensitivity
to others.
h Score ranges from 6 to 30, with a higher score indicating ease at handing
new situations.
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sex was found to be negatively associated with total
empowerment and all empowerment subscales except
Social Support. Employment and education were found
to be positively associated with the empowerment subscale
of Personal Strength. Higher stage of disease was posi-
tively associated with the subscale of Social Support. Palli-
ative treatment intent was found to be negatively
associated with Personal Strength. With regard to auton-
omy, self-awareness and capacity to handle new situations
were positively associated with total empowerment and all
subscales except Self-Awareness and the empowerment
Community subscale. On the autonomy subscale, sensi-
tivity to others was found to be negatively associated with
total empowerment and the empowerment Community
subscale. Perception of social support demonstrated a
strong positive association with total empowerment and
all empowerment subscales. Coping difficulties and psy-
chological distress were negatively associated with total
empowerment and all subscales except for the empower-
ment Community subscale.
In multivariate linear analysis, using total empower-
ment as outcome and including univariately significant
correlates (except for psychological distress, which was
highly correlated with coping [correlation coefficient of
>0.8]), the results remained significant for self-awareness
(b5 .35; P<.01), new situations (b5 .19; P5 .05), cop-
ing difficulties (b5 -.19; P5 .04), and social support (b
5 .35; P<.01), but not sex (b 5 -.14; P 5 .11) or sensi-
tivity to others (b5 .08; P5 .38).
Associations Between Empowerment
and HRQOL Among AYA Patients
Bivariate correlations demonstrated that all empowerment
subscales were positively associated with HRQOL, except
for the Community subscale, which was not associated with
physical and psychological HRQOL. Several sociodemo-
graphic, clinical, and personal factors also were found to be
significantly associated with HRQOL (Table 3).
Female sex was negatively associated with all
HRQOL subscales except for the religious subscale. Hav-
ing work or attending school was positively associated
with the religious HRQOL subscale. Completion of can-
cer treatment was positively associated with the physical
HRQOL subscale. Palliative treatment intent was nega-
tively associated with all HRQOL scales except the social
subscale. The autonomy subscale of Self-Awareness was
found to be positively associated with total and social
HRQOL. The autonomy subscale demonstrated that
TABLE 2. Associated Factors of Empowerment
Personal
Strength Social Support Community Health Care Total
Sociodemographic and clinical factors
Age at diagnosis, y 20.05 20.10 20.01 20.16 20.08
Gender: 0 for male and 1 for female 20.26a 20.21 20.28a 20.31b 20.32b
Partner: 0 for yes and 1 for no 20.21 20.12 20.13 20.06 20.19
Educational levelc 0.20 0.09 20.04 0.05 0.13
Living statusd 20.05 20.03 20.08 20.09 20.07
Work/school: 0 for no and 1 for yes 0.22a 20.03 20.13 20.02 0.07
Children: 0 for no and 1 for yes 0.04 20.01 20.03 20.09 20.01
Time since diagnosis, y 0.07 20.03 20.18 0.03 20.01
Disease stagee 20.12 0.26a 0.11 0.17 0.01
Treatment statusf 0.03 20.12 20.09 0.06 20.02
Treatment intentg 20.23a 20.10 0.01 20.08 20.16
Chemotherapy: 0 for no and 1 for yes 0.13 0.09 0.03 0.09 0.12
Autonomy connectedness
Self-awareness 0.55b 0.47b 0.19 0.27a 0.51a
Sensitivity to others 20.21 20.14 20.24a 20.07 20.22a
Capacity for new situations 0.51b 0.42b 0.23a 0.27a 0.48b
Other
Amount of social support meeting needs 0.34b 0.46b 0.39b 0.46b 0.48b
Coping difficulties 20.47b 20.23a 20.11 20.25a 20.38b
Psychological distress 20.66b 20.48b 20.16 20.37b 20.58b
aP<.05.
bP<.01.
c 0 indicates low/intermediate vocational education or less and 1 indicates high-level vocational education/university.
d 0 indicates with parent and 1 indicates independent/together with partner (children) or friends.
e 0 indicates stages I and II and 1 indicates stages III and IV.
f 0 indicates receiving treatment and 1 indicates completed treatment.
g 0 indicates curative and1 indicates palliative.
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sensitivity to others was negatively associated with psycho-
logical, social, and total HRQOL. In addition, the auton-
omy subscale capacity to handle new situations had a
strong positive association with all HRQOL scales except
the religious subscale.
To assess the independent association of empower-
ment with the 5 HRQOL scales, multivariate linear
regression analyses were conducted with HRQOL scales
as outcomes, total empowerment score as an independent
variable, and including all significant correlates in univari-
ate analyses. Empowerment remained significant for
physical (b 5 .31; P<.01), psychological (b 5 .50;
P<.01), social (b 5 .39; P<.01), religious (b 5 .33;
P<.01), and total HRQOL (b5 .52; P<.01).
Sensitivity analysis demonstrated that the empower-
ment scales were only significantly associated with
HRQOL for those patients treated with curative intent
and not for those treated with palliative intent.
DISCUSSION
The results of the current study indicate that AYA patients
with cancer who were treated in a specialized care center
had relatively high levels of empowerment. There was a
wide range of levels of empowerment, indicating room for
improvement. Empowerment levels in the current study
were comparable to those in a previous study in patients
with breast cancer; however, this study only included
female patients who were older than patients in the cur-
rent study sample.21 The results of the current study dem-
onstrated that the most important factors associated with
empowerment in AYA patients were autonomy, sex, social
support and coping. This provides beneficial insight into
groups that may benefit from support interventions that
aim to empower AYA patients. AYA patients with higher
levels of empowerment were more likely to be male, have
higher autonomy scores, and to receive more social sup-
port. These patients also reported fewer difficulties in cop-
ing and lower levels of psychological distress. The current
study data have demonstrated the importance of high lev-
els of empowerment because this was found to be posi-
tively associated with HRQOL.
Autonomy was strongly associated with empower-
ment. Self-awareness and the capacity to handle new sit-
uations were independently associated with total
empowerment. Developing autonomy is generally experi-
enced as young people mature.22 Although many AYA
TABLE 3. Correlations Between Empowerment, Other Covariates, and HRQOL
Physical Psychological Social Religious Total HRQOL
Empowerment
Personal strength 0.45a 0.63a 0.42a 0.29a 0.65a
Social support 0.26b 0.43a 0.40a 0.22b 0.46a
Community 0.21 0.21 0.22b 0.24b 0.28b
Health care 0.41a 0.42a 0.45a 0.27b 0.52a
Total 0.44a 0.58a 0.47a 0.32a 0.63a
Sociodemographic and clinical
Age at diagnosis, y 20.18 20.11 0.01 20.05 20.12
Age at survey, y 20.13 20.05 0.10 20.05 20.05
Sex: 0 for male and 1 for female 20.35a 20.39a 20.35a 20.16 20.43a
Partner: 0 for yes and 1 for no 20.11 20.09 0.05 20.15 20.09
Educational levelc 0.15 0.01 20.18 0.15 0.03
Living statusd 20.01 20.07 0.02 0.01 20.03
Work/school: 0 for no and 1 for yes 0.22b 0.17 20.09 0.37a 0.20
Children: 0 for no and 1 for yes 0.11 20.04 0.04 20.01 0.02
Time since diagnosis, y 0.04 0.03 0.11 0.02 0.06
Disease stagee 20.11 20.17 20.04 20.23 20.19
Treatment statusf 0.27b 0.16 0.04 0.10 0.18
Treatment intentg 20.27b 20.31a 20.13 20.30a 20.35a
Chemotherapy: 0 for no and 1 for yes 0.14 0.18 0.10 20.05 0.16
Autonomy-connectedness
Self-awareness 0.14 0.20 0.25b 0.12 0.25b
Sensitivity to others 20.01 20.31a 20.32a 0.07 20.24b
Capacity for new situations 0.31a 0.36a 0.25b 0.20 0.40a
Abbreviation: HRQOL, health-related quality of life.
aP<.01.
bP<.05.
c 0 indicates low/intermediate vocational education or less and 1 indicates high-level vocational education/university.
d 0 indicates with parent and 1 indicates independent/together with partner (children) or friends.
e 0 indicates stages I and II and 1 indicates stages III and IV.
f 0 indicates receiving treatment and 1 indicates completed treatment.
g 0 indicates curative and 1 indicates palliative.
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patients have developed decision-making skills regarding
their own health or life goals,22 others will still look to
others to help them with decision making and indeed they
may return to a state of dependency when faced with can-
cer.23 Health-related information should be delivered in a
manner that is appropriate to the age of the patient
because this is critical in helping AYA individuals learn to
cope with their disease and navigate the health care sys-
tem.24 The capacity to handle new situations is closely
related to the concept of coping. In their relatively short
lives, the majority of AYA patients have not encountered
many major life events. AYA patients may require more
support because they have not had the opportunity to
develop skills that enable them to cope with new and chal-
lenging situations.We found that being female had a signif-
icant, negative correlation with empowerment. This may
be explained by the findings of a study that demonstrated
that women tend to use less effective, emotion-focused cop-
ing strategies whereas men use more effective problem-
focused or instrumental methods of handling stressful expe-
riences.25 Additional support for female AYA patients may
be warranted; however, we should not assume that all male
AYA patients will require less social support.
Although AYA patients often feel isolated, perceived
social support from family and friends contributes to high
levels of empowerment.7 A cancer diagnosis and its treat-
ment lead to increased dependency on parents and/or
partners and sets AYA patients apart from their healthy
peers. AYA autonomy and the development of identity in
general depends largely on peer acceptance and relation-
ships.26 Not unexpectedly, studies have shown that sup-
port from other AYA patients with cancer is incredibly
important for this age group in helping them to cope with
their disease.27 In addition, AYA patients want to provide
support to their own family and friends to create a sense
of self-worth; however, this contribution is not always
possible during their disease trajectory due to the effects of
cancer and its treatment.28 Those with high levels of sensi-
tivity toward others, more commonly women, have
greater difficulty accepting this realization and therefore
feel less empowered.25 As the results of the current study
demonstrate, return into society, through employment or
education, contributes further to empowerment by creat-
ing a sense of self-worth/confidence and perceiving one-
self as being useful. A perceived lack of social support and
the absence of self-worth and appropriate coping skills
may all have a negative effect on psychological distress,
which itself is a strong negative correlate of empower-
ment. Last, the results of the current study demonstrate
that treatment intent (curative vs palliative) also
contributes to the levels of personal strength. The needs of
AYA patients with advanced cancer intensify as they near
the end of their lives.29 The physical changes associated
with advanced disease result in a loss of capacity to man-
age activities of daily living and aspects of medical regi-
mens.5 In addition, the stress of living with an enduring
sense of loss brings new challenges, such as when to hand
responsibilities to others and whether to discuss emotional
or spiritual concerns and end-of-life decisions. Providing
appropriate support to allow patients to maintain a level
of autonomy is very important in this phase.5
Given the strong correlation between empowerment
and HRQOL found in the current study and others,30
and the relatively high levels of empowerment measured
in this AYA sample, strategies to reinforce empowerment
in AYA patients should be explored. Interventions could
focus on 1 or all 4 domains of empowerment. First, the
sense of personal strength can be positively influenced by
self-management (ie, the comprehensive engagement of
the AYA patient in problem solving, decision making, and
daily health-related behaviors in partnership with health
care professionals and community).31 Self-management
will help patients to manage the medical aspects of cancer
by managing life roles (including changes in roles brought
by cancer) and managing the psychosocial consequences
of cancer.32 Such a self-management intervention might
include cognitive behavioral therapy components such as
psychoeducation, cognitive reframing, goal planning, and
process evaluation.33 Second, social support can be
enhanced by offering real-life and digital platforms for
AYA patients in which they can virtually meet and share
information and feelings with peers (unpublished data).
For example, online peer support groups and age-specific
information portals for AYA patients have been shown to
significantly reduce feelings of social isolation, and
improve knowledge, self-efficacy, problem-solving skills,
and effective interpersonal interactions.34 With regard to
the third empowerment dimension, community, atten-
tion should be paid to reframing the perception of AYA
patients as a burden to society. The fourth empowerment
dimension, health care, can be improved by creating inpa-
tient and outpatient dedicated multifunctional spaces to
suit the needs of AYA patients, training AYA-dedicated
professional caregivers, and establishing educational pro-
grams for health care professionals. For example, addi-
tional medical training in fertility preservation or AYA
survivorship care could be provided at the (under)gradu-
ate level, in primary care residencies, and adult oncology
fellowships. Future research should explore the best ways
to increase levels of empowerment among AYA patients.
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The current study has several limitations. First, all
participants were treated in a single center and received
multidisciplinary care by a dedicated AYA team. There-
fore, it could be that the empowerment levels of the cur-
rent study sample are higher than those of AYA patients
treated in other centers in the Netherlands without age-
specific care. However, the patients in the current study
sample were diagnosed with a relatively advanced stage of
disease and were treated intensively, mostly with>1 treat-
ment modality. This might be an overestimation in dis-
ease severity of the entire AYA cancer population, in
which lower stage disease (cervical cancer, melanoma, thy-
roid cancer, and brain tumor) treated solely by surgery is
more common. Both factors limit the generalizability of
the results of the current study. A second limitation of the
current study is the low response rate, which is not
unusual in studies in young patients with cancer but was
even lower than in previous questionnaire studies35,36
among AYA patients (29% response rate in the current
study sample vs 43% and 52% in previous studies).
Unfortunately, we do not have information regarding the
reasons for no participation. Because demographic data
were not collected from the nonresponders, we could not
rule out selection bias. Third, empowerment is rarely for-
mally assessed as outcome and to our knowledge a few val-
idated questionnaires exist, particularly for the cancer
setting,6 therefore making it difficult to compare the
results of the current study with those from other groups
of patients with cancer. Fourth, the cross-sectional design
of the current study limits the determination of causal
associations between the study variables. Longitudinal
research is needed to assess changes in empowerment lev-
els over time to determine the best time to intervene for
those patients with low levels. Fifth, the question remains
whether the higher levels of empowerment are caused by
the fact that all AYA patients consulted at least 1 member
of the multidisciplinary AYA team, or by the psychomet-
ric properties of the empowerment questionnaire.
Although the CEQ has demonstrated good psychometric
properties, to the best of our knowledge the sensitivity
and specificity of this instrument have not been tested and
there is no validated cutoff point in the cancer setting.
Empowerment is an important factor related to
HRQOL in late adolescence and young adulthood.
Empowerment levels as measured in the current study
were quite high in AYA patients with cancer who were
treated in a specialized care center. Low levels of empow-
erment were associated with low levels of autonomy and
social support, female sex, and coping difficulties. Future
research should explore the best ways to increase empow-
erment in identified risk groups.
FUNDING SUPPORT
No specific funding was disclosed.
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
AUTHOR CONTRIBUTIONS
Conceptualization: Suzanne E.J. Kaal, Olga Husson, Judith B.
Prins, and Winette T.A. van der Graaf. Methodology: Suzanne
E.J. Kaal, Olga Husson, and Petra Servaes. Validation: Suzanne
E.J. Kaal and Olga Husson. Formal analysis: Suzanne E.J. Kaal,
Olga Husson, and Saskia van Duivenboden. Investigation:
Suzanne E.J. Kaal and Rosemarie Jansen. Resources: Suzanne
E.J. Kaal, Olga Husson, and Rosemarie Jansen. Data curation:
Suzanne E.J. Kaal and Olga Husson. Writing–original draft:
Suzanne E.J. Kaal, Olga Husson, Saskia van Duivenboden, and
Sanne W. van den Berg. Writing–review and editing: All authors.
Visualization: Suzanne E.J. Kaal. Supervision: Olga Husson,
Judith B. Prins, Sanne W. van den Berg, Winette T.A. van der
Graaf. Project administration: Suzanne E.J. Kaal.
REFERENCES
1. Ferrari A, Thomas D, Franklin AR, et al. Starting an adolescent and
young adult program: some success stories and some obstacles to
overcome. J Clin Oncol. 2010;28:4850-4857.
2. Barr RD, Ferrari A, Ries L, Whelan J, Bleyer WA. Cancer in adoles-
cents and young adults: a narrative review of the current status and a
view of the future. JAMA Pediatr. 2016;170:495-501.
3. Integraal Kankercentrum Nederland. Nederlandse Kankerregistra-
tie.http://www.cijfersoverkanker.nl. Accessed November 2016.
4. Zebrack BJ. Psychological, social, and behavioral issues for young
adults with cancer. Cancer. 2011;117(suppl 10):2289-2294.
5. McCorkle R, Ercolano E, Lazenby M, et al. Self-management:
enabling and empowering patients living with cancer as a chronic ill-
ness. CA Cancer J Clin. 2011;61:50-62.
6. Maunsell E, Lauzier S, Brunet J, et al. Health-related empowerment
in cancer: validity of scales from the Health Education Impact Ques-
tionnaire. Cancer. 2014;120:3228-3236.
7. Groen WG, Kuijpers W, Oldenburg HS, Wouters MW, Aaronson
NK, van Harten WH. Empowerment of cancer survivors through
information technology: an integrative review. J Med Internet Res.
2015;17:e270.
8. van den Berg SW, van Amstel FK, Ottevanger PB, Gielissen MF,
Prins JB. The Cancer Empowerment Questionnaire: psychological
empowerment in breast cancer survivors. J Psychosoc Oncol. 2013;31:
565-583.
9. Ryhanen AM, Rankinen S, Siekkinen M, Saarinen M, Korvenranta
H, Leino-Kilpi H. The impact of an empowering Internet-based
Breast Cancer Patient Pathway program on breast cancer patients’
clinical outcomes: a randomised controlled trial. J Clin Nurs. 2013;
22:1016-1025.
10. Te Boveldt N, Vernooij-Dassen M, Leppink I, et al. Patient empow-
erment in cancer pain management: an integrative literature review.
Psychooncology. 2014;23:1203-1211.
11. Rappaport J. Studies in empowerment: introduction to the issue.
Prevention in Human Services 1984:3:1–7.
12. Castro EM, Van Regenmortel T, Vanhaecht K, Sermeus W, Van
Hecke A. Patient empowerment, patient participation and patient-
centeredness in hospital care: a concept analysis based on a literature
review. Patient Educ Couns. 2016;99:1923-1939.
Original Article
4046 Cancer October 15, 2017
13. Bravo P, Edwards A, Barr PJ, Scholl I, Elwyn G, McAllister M;
Cochrane Healthcare Quality Research Group, Cardiff University.
Conceptualising patient empowerment: a mixed methods study.
BMC Health Serv Res. 2015;15:252.
14. Zimmerman MA, Warschausky S. Empowerment theory for rehabil-
itation research: conceptual and methodological issues. Rehabil Psy-
chol. 1998;43:3-16.
15. Zimmerman MA. Psychological empowerment: issues and illustra-
tions. Am J Community Psychol. 1995;23:581-599.
16. Eskildsen NB, Joergensen CR, Thomsen TG, et al. Patient empow-
erment: a systematic review of questionnaires measuring empower-
ment in cancer patients. Acta Oncol. 2017;56:156-165.
17. Ferrell BR, Dow KH, Grant M. Measurement of the quality of life
in cancer survivors. Qual Life Res. 1995;4:523-531.
18. Rutten EA, Bachrach N, van Balkom AJ, Braeken J, Ouwens MA,
Bekker MH. Anxiety, depression and autonomy-connectedness: the
mediating role of alexithymia and assertiveness. Psychol Psychother.
2016;89:385-401.
19. Bekker MH, van Assen MA. A short form of the Autonomy Scale:
properties of the Autonomy-Connectedness Scale (ACS-30). J Pers
Assess. 2006;86:51-60.
20. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression
Scale. Acta Psychiatr Scand. 1983;67:361-370.
21. van den Berg SW, Gielissen MF, Custers JA, Van der Graaf WT,
Ottevanger PB, Prins JB. BREATH: Web-based self-management
for psychological adjustment after primary breast cancer–results of a
multicenter randomized controlled trial. J Clin Oncol. 2015;33:
2763-2771.
22. Davies J, Kelly D, Hannigan B. Autonomy and dependence: a dis-
cussion paper on decision-making in teenagers and young adults
undergoing cancer treatment. J Adv Nurs. 2015;71:2031-2040.
23. Grinyer A. Young adults with cancer: parents’ interactions with
health care professionals. Eur J Cancer Care (Engl). 2004;13:88-95.
24. D’Agostino NM, Penney A, Zebrack B. Providing developmentally
appropriate psychosocial care to adolescent and young adult cancer
survivors. Cancer. 2011;117(suppl 10):2329-2334.
25. Kelly MM, Tyrka AR, Price LH, Carpenter LL. Sex differences in
the use of coping strategies: predictors of anxiety and depressive
symptoms. Depress Anxiety. 2008;25:839-846.
26. Suris JC, Michaud PA, Viner R. The adolescent with a chronic condi-
tion. Part I: developmental issues. Arch Dis Child. 2004;89:938-942.
27. Hollis R, Morgan S. The adolescent with cancer–at the edge of no-
man’s land. Lancet Oncol. 2001;2:43-48.
28. Belpame N, Kars MC, Beeckman D, et al. “The AYA Director”: a syn-
thesizing concept to understand psychosocial experiences of adolescents
and young adults with cancer. Cancer Nurs. 2016;39:292-302.
29. Hughes RE, Holland LR, Zanino D, Link E, Michael N,
Thompson KE. Prevalence and intensity of pain and other physical
and psychological symptoms in adolescents and young adults diag-
nosed with cancer on referral to a palliative care service. J Adolesc
Young Adult Oncol. 2015;4:70-75.
30. Cho D, Park CL. Moderating effects of perceived growth on the
association between fear of cancer recurrence and health-related qual-
ity of life among adolescent and young adult cancer survivors.
J Psychosoc Oncol. 2017;35:148-165.
31. Lorig KR, Holman H. Self-management education: history, defini-
tion, outcomes, and mechanisms. Ann Behav Med. 2003;26:1-7.
32. Adams K, Greiner A, Corrigan J. Report of a Summit: First Annual
Crossing the Quality Chasm Summit: A Focus on Communities.
Washington DC: National Academic Press; 2004.
33. van den Berg SW, Gielissen MF, Ottevanger PB, Prins JB. Rationale
of the BREAst cancer e-healTH [BREATH] multicentre randomised
controlled trial: an internet-based self-management intervention to
foster adjustment after curative breast cancer by decreasing distress
and increasing empowerment. BMC Cancer. 2012;12:394.
34. Roberts CS, Piper L, Denny J, Cuddeback G. A support group
intervention to facilitate young adults’ adjustment to cancer. Health
Soc Work. 1997;22:133-141.
35. Bellizzi KM, Smith A, Schmidt S, et al; Adolescent and Young Adult
Health Outcomes and Patient Experience (AYA HOPE) Study Col-
laborative Group. Positive and negative psychosocial impact of being
diagnosed with cancer as an adolescent or young adult. Cancer.
2012;118:5155-5162.
36. Murnane A, Gough K, Thompson K, Holland L, Conyers R. Ado-
lescents and young adult cancer survivors: exercise habits, quality of
life and physical activity preferences. Support Care Cancer. 2015;23:
501-510.
Empowerment in AYA Patients With Cancer/Kaal et al
Cancer October 15, 2017 4047
